A PLACEBO-CONTROLLED TRIAL OF MEMANTINE AS AN ADJUNCT TO INJECTABLE EXTENDEDRELEASE NALTREXONE FOR OPIOID DEPENDENCE

There is preclinical support for using NMDA receptor glutamatergic antagonists to aid in naltrexone-based treatment of opioid dependence. We hypothesized that adding memantine will improve efficacy of extended-release (XR) naltrexone to prevent relapse. In this double blind study opioid-dependent pa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bisaga, Adam, Sullivan, Maria A., Glass, Andrew, Mishlen, Kaitlyn, Carpenter, Kenneth M., Mariani, John J, Levin, Frances R., Nunes, Edward V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007510/
https://ncbi.nlm.nih.gov/pubmed/24560438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2014.01.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak